FDA Targets Cancer Indications That Fail to Prove Benefit 03/17/2021 Health News, US regulators are stepping up scrutiny of cancer indications that were granted an accelerated approval...
FDA Targets Cancer Indications That Fail to Prove Benefit 03/17/2021 Health News, US regulators are stepping up scrutiny of cancer indications that were granted an accelerated approval...
Checkpoint Inhibitor Rheumatic Complications Often Arise Late 03/16/2021 Health News, Dr Eric M. Ruderman Most checkpoint inhibitor–induced rheumatic complications in cancer patients can be treated...
FDA Approves Libtayo (cemiplimab-rwlc) as First Immunotherapy Indicated for Patients with Advanced Basal Cell Carcinoma 02/10/2021 Medications, TARRYTOWN, N.Y. and PARIS, Feb. 9, 2021 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi...
Study identifies patients with lung cancer most likely to respond to immunotherapy 11/16/2020 Health News, Scientists are beginning to unravel one of the biggest challenges with immunotherapy: why some people...
Immunotherapy prior to surgery is effective in colon cancer 04/06/2020 Health News, Patients with colon cancer but without distant metastases can benefit from a short course of...
New type of immunotherapy hinders the spread of ovarian cancer 03/26/2020 Health News, Malignant ovarian cancer is insidious: Known and feared for vague and uncharacteristic symptoms that often...
Immunotherapy improves five-year survival rate of people with advanced lung cancer 06/03/2019 Medications, In a study led by UCLA investigators, treatment with the immunotherapy drug pembrolizumab helped more...